Khan, Irfan

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality

Wadhera, R. K., Steen, D. L., Khan, I., Giugliano, R. P., & Foody, J. M. (2016) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 306

Quantifying importance of major risk factors for coronary heart disease

Pencina, M. J., Navar, A. M., Wojdyla, D., Sanchez, R. J., Khan, I., Elassal, J., D’Agostino, R. B., Peterson, E. D., & Sniderman, A. D. (2019) · Circulation

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 247

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan

Teramoto, T., Uno, K., Miyoshi, I., Khan, I., Gorcyca, K., Sanchez, R. J., Yoshida, S., Mawatari, K., Masaki, T., Arai, H., et al. (2016) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 71

Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands

Kuiper, J. G., Sanchez, R. J., Houben, E., Heintjes, E. M., Penning-van Beest, F. J. A., Khan, I., van Riemsdijk, M., & Herings, R. M. C. (2017) · Clinical Therapeutics

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 48

Association of cinacalcet adherence and costs in patients on dialysis

Lee, A., Song, X., Khan, I., Belozeroff, V., Goodman, W., Fulcher, N., & Diakun, D. (2011) · Journal of Medical Economics

Medication Adherence and ComplianceParathyroid Disorders and Treatments

Cited by 33